SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Politics : A US National Health Care System?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: i-node who wrote (6456)3/24/2009 5:30:14 PM
From: Peter Dierks  Read Replies (1) of 42652
 
Rather than trying to force pharmaceuetical providers to do R&D without compensation a better approach would be to attach an export tax on all prescriptions drugs that are more costly in the US than the destination.

In the case where manufacturing is moved overseas then attach punitive tariffs to other goods from those countries.

For the US the only real cost savings is to find a mechanism to get other first world countries plus Europe to pay a pro rata share of the R&D costs that are now primarily born by American consumers. I don't know what the mechanism would be, but it is where the real cost savings lay.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News